Urocortin stimulates ERK1/2 phosphorylation and proliferation but reduces ATP production of MCF7 breast cancer cells

Mol Cell Endocrinol. 2022 May 1:547:111610. doi: 10.1016/j.mce.2022.111610. Epub 2022 Feb 24.

Abstract

Urocortins are members of the stress-related corticotropin-releasing factor family. Small amounts of them are present in the circulation and they are produced locally in various tissues of higher vertebrates. Aside from regulating circulation, or food uptake they also influence, via auto- and paracrine mechanisms, cell proliferation. In the present study we investigated in MCF7 human breast cancer cells the effect of urocortin onto mitogenic signaling via ERK1/2. Our results revealed that already 10 nM urocortin could stimulate the phosphorylation of these kinases and cell proliferation of MCF7 cells while ATP production was reduced when kept in the presence of the peptide up to two days. We examined the expression and contribution of the specific receptors of urocortin to the activation of ERK1/2 and to cell proliferation, the intracellular distribution of phosphorylated ERK1/2, and the involvement of additional proteins like PKA, PKB/Akt, MEK, p53, Rb and E2F-1 behind the observed phenomena.

Keywords: Cell proliferation; E2F; ERK1/2; MCF7; Retinoblastoma; Urocortin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Breast Neoplasms*
  • Cell Proliferation
  • Corticotropin-Releasing Hormone / metabolism
  • Female
  • Humans
  • MAP Kinase Signaling System
  • MCF-7 Cells
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Phosphorylation
  • Receptors, Corticotropin-Releasing Hormone / metabolism
  • Urocortins* / pharmacology

Substances

  • Receptors, Corticotropin-Releasing Hormone
  • Urocortins
  • Adenosine Triphosphate
  • Corticotropin-Releasing Hormone
  • Mitogen-Activated Protein Kinase 1